Article ID: 719072
Rutgers Cardiologist Advocates for Personalized Treatment with Aspirin as Primary Prevention in Cardiovascular DiseaseRutgers Robert Wood Johnson Medical School
A nationally recognized Rutgers cardiologist recommends that aspirin be used as primary prevention for cardiovascular disease only with select patients, saying that the scientific evidence is too diverse to support a one-size-fits-all approach.
Released:17-Sep-2019 10:05 AM EDT
Article ID: 718957
Cancer Protocols: A New Approach to Predicting Treatment OutcomesWeizmann Institute of Science
Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responses
Released:13-Sep-2019 1:45 PM EDT
Article ID: 717884
Drug Resistance Signature Discovered in Crohn’s DiseaseMount Sinai Health System
Finding May Create Opportunity to Test Patients to Avoid Ineffective Drugs
Released:22-Aug-2019 2:05 PM EDT
Article ID: 717865
Moffitt Researchers Develop Model to Personalize Radiation Treatment for Breast Cancer PatientsMoffitt Cancer Center
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has not translated to radiation therapy, and a one-size-fits-all approach for most patients is still common practice. Moffitt Cancer Center researchers hope to change this mindset for radiation treatment with the development of a genomically-based model that can optimize and personalize a radiation dose to match an individual patient’s needs.
Released:22-Aug-2019 10:50 AM EDT
Article ID: 717247
Adding MS Drug to Targeted Cancer Therapy May Improve Glioblastoma OutcomesUniversity of California San Diego Health
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
Released:8-Aug-2019 4:50 PM EDT
Article ID: 716114
Experts to Demystify Direct-to-Consumer Genetic Testing at the 71st AACC Annual Scientific MeetingAmerican Association for Clinical Chemistry (AACC)
On August 4, a special session at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo will shed much-needed light on the nuances of direct-to-consumer genetic testing.
Released:22-Jul-2019 8:55 AM EDT
Genetics, Healthcare, Patient Safety, Biotech, Cancer, Cardiovascular Health, Cell Biology, Chemistry, Diabetes, Ethics and Research Methods, Family and Parenting, Heart Disease, In the Home, Marketing, Media and Journalism, Men's Health, Mental Health, Personalized Medicine, Pharmaceuticals, Race and Ethnicity, Social Media, Technology, Weight Loss, Women's Hea,
Article ID: 716595
CHOP Research Team Redefines the Footprint of Viral Vector Gene TherapyChildren's Hospital of Philadelphia
Building on a track record of developing adeno-associated viral (AAV) vectors as a groundbreaking clinical tool for gene therapy and gene editing, Children’s Hospital of Philadelphia (CHOP) researchers report a more sensitive method for capturing the footprint of AAV vectors—a broad range of sites where the vectors transfer genetic material.
Released:30-Jul-2019 9:00 AM EDT
Article ID: 716429
Pediatricians first in the field to assess how to personalize treatment for hypertension in childrenUniversity of Texas Health Science Center at Houston
High blood pressure among children is on the rise and a lack of research about how to treat it has left pediatricians trying to make their best guess. That’s until researchers released results of a pioneering study that used a series of personalized trials to identify a preferred therapy for kids – the first step in tackling the problem.
Released:26-Jul-2019 8:05 AM EDT
Article ID: 716359
Expanding the limits of personalized medicine with high-performance computingArgonne National Laboratory
Imagine that you have a serious medical condition. Then imagine that when you visit a team of doctors, they could build an identical virtual ‘twin’ of the condition and simulate millions of ways to treat it until they develop an effective treatment. That is the vision of a team of scientists, led by Argonne National Laboratory.
Released:24-Jul-2019 5:05 PM EDT
Article ID: 716062
New technique helps create more personalized therapies for people with hard-to-treat cancersUniversity of California, Los Angeles (UCLA), Health Sciences
Using an ultra-sensitive and high-throughput isolation technology, UCLA researchers were able to characterize and identify the neoantigens driving the antitumor responses in a patient treated with anti-PD-1 blockade and isolate the T cell receptors responsible for such effect.
Released:18-Jul-2019 3:05 PM EDT